El-Bassossy HM - Search Results

1

Sustained linagliptin administration: superior glycemic control and less pancreatic injury in diabetic rats.

Zakaria EM, El-Gamal SF, Mahmoud SM, El-Nahas HM, El-Bassossy HM. Zakaria EM, et al. Among authors: el bassossy hm. Pharm Dev Technol. 2024 Oct;29(8):874-885. doi: 10.1080/10837450.2024.2407852. Epub 2024 Sep 30. Pharm Dev Technol. 2024. PMID: 39311002

2

Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control.

Gomaa E, Eissa NG, Ibrahim TM, El-Bassossy HM, El-Nahas HM, Ayoub MM. Gomaa E, et al. Among authors: el bassossy hm. Saudi Pharm J. 2023 Apr;31(4):499-509. doi: 10.1016/j.jsps.2023.02.002. Epub 2023 Feb 13. Saudi Pharm J. 2023. PMID: 37063437 Free PMC article.

3

PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals.

Zakaria EM, El-Bassossy HM, El-Maraghy NN, Ahmed AF, Ali AA. Zakaria EM, et al. Eur J Pharmacol. 2016 Nov 15;791:444-454. doi: 10.1016/j.ejphar.2016.09.008. Epub 2016 Sep 6. Eur J Pharmacol. 2016. PMID: 27612628

4

Investigation of Alogliptin-Loaded In Situ Gel Implants by 2³ Factorial Design with Glycemic Assessment in Rats.

Ibrahim TM, Ayoub MM, El-Bassossy HM, El-Nahas HM, Gomaa E. Ibrahim TM, et al. Among authors: el bassossy hm. Pharmaceutics. 2022 Sep 5;14(9):1867. doi: 10.3390/pharmaceutics14091867. Pharmaceutics. 2022. PMID: 36145615 Free PMC article.

5

PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.

Zakaria EM, El-Maraghy NN, Ahmed AF, Ali AA, El-Bassossy HM. Zakaria EM, et al. Naunyn Schmiedebergs Arch Pharmacol. 2017 Jun;390(6):621-631. doi: 10.1007/s00210-017-1360-9. Epub 2017 Feb 21. Naunyn Schmiedebergs Arch Pharmacol. 2017. PMID: 28224182

6

Psiadia punctulata major flavonoids alleviate exaggerated vasoconstriction produced by advanced glycation end products.

Abdallah HM, Zakaria EM, El-Halawany AM, Mohamed GA, Safo MK, El-Bassossy HM. Abdallah HM, et al. PLoS One. 2019 Sep 6;14(9):e0222101. doi: 10.1371/journal.pone.0222101. eCollection 2019. PLoS One. 2019. PMID: 31491007 Free PMC article.

7

Cardioprotection by 6-gingerol in diabetic rats.

El-Bassossy HM, Elberry AA, Ghareib SA, Azhar A, Banjar ZM, Watson ML. El-Bassossy HM, et al. Biochem Biophys Res Commun. 2016 Sep 2;477(4):908-914. doi: 10.1016/j.bbrc.2016.06.157. Epub 2016 Jul 1. Biochem Biophys Res Commun. 2016. PMID: 27378426

8

Vitamin B1 and calcitriol enhance glibenclamide suppression of diabetic nephropathy: Role of HMGB1/TLR4/NF-κB/TNF-α/Nrf2/α-SMA trajectories.

ElKhooly IA, El-Bassossy HM, Mohammed HO, Atwa AM, Hassan NA. ElKhooly IA, et al. Among authors: el bassossy hm. Life Sci. 2024 Nov 15;357:123046. doi: 10.1016/j.lfs.2024.123046. Epub 2024 Sep 8. Life Sci. 2024. PMID: 39255926

9

Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation.

Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A. Mahmoud MF, et al. PLoS One. 2013 May 22;8(5):e63784. doi: 10.1371/journal.pone.0063784. Print 2013. PLoS One. 2013. PMID: 23717483 Free PMC article.

10

Geraniol alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress.

El-Bassossy HM, Ghaleb H, Elberry AA, Balamash KS, Ghareib SA, Azhar A, Banjar Z. El-Bassossy HM, et al. Biomed Pharmacother. 2017 Apr;88:1025-1030. doi: 10.1016/j.biopha.2017.01.131. Epub 2017 Feb 6. Biomed Pharmacother. 2017. PMID: 28178614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters